Copyright Reports & Markets. All rights reserved.

Global Pemetrexed Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Pemetrexed Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 100mg
      • 1.2.2 500mg
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital Pharmacies
      • 1.3.2 Retail Pharmacies
      • 1.3.3 Online Pharmacies
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Eli Lilly
      • 2.1.1 Business Overview
      • 2.1.2 Pemetrexed Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Eli Lilly Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Abbott Laboratories
      • 2.2.1 Business Overview
      • 2.2.2 Pemetrexed Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Abbott Laboratories Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Cadila Healthcare
      • 2.3.1 Business Overview
      • 2.3.2 Pemetrexed Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Cadila Healthcare Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Eagle Pharmaceuticals
      • 2.4.1 Business Overview
      • 2.4.2 Pemetrexed Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Eagle Pharmaceuticals Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Stada Arzneimittel
      • 2.5.1 Business Overview
      • 2.5.2 Pemetrexed Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Stada Arzneimittel Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Pemetrexed Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Pemetrexed Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Pemetrexed Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Pemetrexed Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Pemetrexed Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Pemetrexed Market Analysis by Regions

    • 4.1 Global Pemetrexed Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Pemetrexed Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Pemetrexed Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Pemetrexed Sales and Growth Rate (2014-2019)
    • 4.3 Europe Pemetrexed Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Pemetrexed Sales and Growth Rate (2014-2019)
    • 4.5 South America Pemetrexed Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Pemetrexed Sales and Growth Rate (2014-2019)

    5 North America Pemetrexed by Country

    • 5.1 North America Pemetrexed Sales, Revenue and Market Share by Country
      • 5.1.1 North America Pemetrexed Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Pemetrexed Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Pemetrexed Sales and Growth Rate (2014-2019)
    • 5.3 Canada Pemetrexed Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Pemetrexed Sales and Growth Rate (2014-2019)

    6 Europe Pemetrexed by Country

    • 6.1 Europe Pemetrexed Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Pemetrexed Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Pemetrexed Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Pemetrexed Sales and Growth Rate (2014-2019)
    • 6.3 UK Pemetrexed Sales and Growth Rate (2014-2019)
    • 6.4 France Pemetrexed Sales and Growth Rate (2014-2019)
    • 6.5 Russia Pemetrexed Sales and Growth Rate (2014-2019)
    • 6.6 Italy Pemetrexed Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Pemetrexed by Country

    • 7.1 Asia-Pacific Pemetrexed Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Pemetrexed Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Pemetrexed Revenue and Market Share by Country (2014-2019)
    • 7.2 China Pemetrexed Sales and Growth Rate (2014-2019)
    • 7.3 Japan Pemetrexed Sales and Growth Rate (2014-2019)
    • 7.4 Korea Pemetrexed Sales and Growth Rate (2014-2019)
    • 7.5 India Pemetrexed Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Pemetrexed Sales and Growth Rate (2014-2019)

    8 South America Pemetrexed by Country

    • 8.1 South America Pemetrexed Sales, Revenue and Market Share by Country
      • 8.1.1 South America Pemetrexed Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Pemetrexed Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Pemetrexed Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Pemetrexed Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Pemetrexed Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Pemetrexed by Countries

    • 9.1 Middle East and Africa Pemetrexed Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Pemetrexed Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Pemetrexed Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Pemetrexed Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Pemetrexed Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Pemetrexed Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Pemetrexed Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Pemetrexed Sales and Growth Rate (2014-2019)

    10 Global Pemetrexed Market Segment by Type

    • 10.1 Global Pemetrexed Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Pemetrexed Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Pemetrexed Revenue and Market Share by Type (2014-2019)
    • 10.2 100mg Sales Growth and Price
      • 10.2.1 Global 100mg Sales Growth (2014-2019)
      • 10.2.2 Global 100mg Price (2014-2019)
    • 10.3 500mg Sales Growth and Price
      • 10.3.1 Global 500mg Sales Growth (2014-2019)
      • 10.3.2 Global 500mg Price (2014-2019)

    11 Global Pemetrexed Market Segment by Application

    • 11.1 Global Pemetrexed Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Pharmacies Sales Growth (2014-2019)
    • 11.3 Retail Pharmacies Sales Growth (2014-2019)
    • 11.4 Online Pharmacies Sales Growth (2014-2019)

    12 Pemetrexed Market Forecast (2019-2024)

    • 12.1 Global Pemetrexed Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Pemetrexed Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Pemetrexed Market Forecast (2019-2024)
      • 12.2.2 Europe Pemetrexed Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Pemetrexed Market Forecast (2019-2024)
      • 12.2.4 South America Pemetrexed Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Pemetrexed Market Forecast (2019-2024)
    • 12.3 Pemetrexed Market Forecast by Type (2019-2024)
      • 12.3.1 Global Pemetrexed Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Pemetrexed Market Share Forecast by Type (2019-2024)
    • 12.4 Pemetrexed Market Forecast by Application (2019-2024)
      • 12.4.1 Global Pemetrexed Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Pemetrexed Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

      Scope of the Report:
      The worldwide market for Pemetrexed is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Pemetrexed in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Eli Lilly
      Abbott Laboratories
      Cadila Healthcare
      Eagle Pharmaceuticals
      Stada Arzneimittel

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      100mg
      500mg

      Market Segment by Applications, can be divided into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Pemetrexed product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Pemetrexed, with price, sales, revenue and global market share of Pemetrexed in 2017 and 2018.
      Chapter 3, the Pemetrexed competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Pemetrexed breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Pemetrexed market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Pemetrexed sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now